cyclohexanol has been researched along with sertraline in 116 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (11.21) | 18.2507 |
2000's | 63 (54.31) | 29.6817 |
2010's | 40 (34.48) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Preskorn, SH | 2 |
Jaffe, IA | 1 |
Althof, SE | 1 |
de Koning, FH; Egberts, AC; Lenderink, AW; Leufkens, HG | 1 |
Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
Mitchell, S; Tracy, KA; Zajecka, J | 1 |
Jaffe, IA; Rudikoff, D | 1 |
Richelson, E | 1 |
Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR | 1 |
Gorman, JM | 1 |
Anand, VS; Dewan, MJ | 1 |
Hwang, W; Kim, KY; Narendran, R | 1 |
Alfaro, CL; Ereshefsky, L; Lam, YW; Simpson, J | 1 |
Behnke, K; Mehtonen, OP; Roponen, P; Søgaard, J | 1 |
Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD | 1 |
Harvey, AT; Preskorn, SH; Rudolph, RL | 1 |
Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH | 1 |
Gottlieb, N | 1 |
Hostetter, A; Ritchie, JC; Stowe, ZN | 1 |
Deslandes, PN; Pache, DM; Sewell, RD; Subhan, F | 1 |
Woods, SW | 1 |
Sheridan, MJ; Wise, TN | 1 |
Caputo, RM; Stern, S; Votolato, NA | 1 |
Fitzgerald, F; Glod, CA; Lynch, A | 1 |
Cook, IA; Leuchter, AF | 1 |
Jacob, C; Luckhaus, C | 1 |
Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S | 1 |
Boskailo, E; Durić-Bijedić, Z; Lewis, J; Pavković, I; Smajkić, A; Weine, S | 1 |
Davis, MW; Fisher, AA | 1 |
Bagby, RM; Kennedy, SH; Vanderkooy, JD | 1 |
Rickels, K; Rynn, M | 1 |
Datto, CJ; DiFilippo, S; Katz, IR; Oslin, DW; Streim, JE; Ten Have, TR; Weintraub, D | 1 |
Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L | 1 |
Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
Carella, A; Cheok, A; Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Potter, WZ; Sagrati, S; Spencer, EP; Wilson, AA | 1 |
Bastiaens, L | 1 |
Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
Burt, T; D'Souza, RF; George, T; Hopwood, M; Lam, W; Martin, AJ; Sir, A; Uguz, S; Vahip, S | 1 |
Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM | 1 |
Lambert, WE; Maudens, KE; Van Peteghem, CH; Wille, SM | 1 |
Giordani, S; Lucca, A; Magri, L; Rossini, D; Smeraldi, E; Zanardi, R | 1 |
Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; Martinez, MI; McElroy, SL; Nolen, WA; Post, RM; Suppes, T | 1 |
Biggs, MM; Fava, M; Luther, JF; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
Higuchi, T; Honda, K; Kamijima, K; Kitahara, S; Tanaka, S; Yamada, M | 1 |
Asnis, G; Benattia, I; Davidson, J; Musgnung, JJ; Rothbaum, BO; Tucker, P | 1 |
Akgoz, S; Akkaya, C; Kirli, S; Sarandol, A; Saygin Eker, S; Yazicioglu, B | 1 |
Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kitchen, CM; Kupka, RW; Leverich, GS; McElroy, S; Mintz, J; Nolen, WA; Post, RM; Suppes, T; Walden, J | 1 |
Eastwood, BJ; Jones, CK; Need, AB; Shannon, HE | 1 |
Leighton, JA; Luckritz, TC; Patel, BM; Rady, MY; Wells, CD; Zornik, JM | 1 |
Bremner, JD; Charney, DS; Vermetten, E; Vythilingam, M | 1 |
Dunner, DL; Haman, KL; Hirschfeld, RM; Kiev, A; Lydiard, RB; Rapaport, MH; Shelton, RC; Smith, WT; Zajecka, JM | 1 |
Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R | 1 |
Connor, K; Davidson, JR; Vaishnavi, S | 1 |
Boovariwala, A; Ginovart, N; Houle, S; Meyer, JH; Rusjan, P; Sagrati, S; Sokolov, S; Spencer, EP; Voineskos, AN; Wilson, AA | 1 |
Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME | 1 |
Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
Jagadheesan, K; Lusicic, A | 1 |
Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
Bonaccorso, S; Girardi, P; Matrisciano, F; Nicoletti, F; Panaccione, I; Ricciardi, A; Ruberto, A; Scaccianoce, S; Shelton, RC; Tatarelli, R; Wang, L | 1 |
Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
Buitelaar, JK; Roobol, TH | 1 |
Muneoka, K; Shioda, S; Shirayama, Y; Takigawa, M | 1 |
Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
Bootzin, E; Millan, MJ; O'Donnell, JM; Zhang, HT; Zhao, Z | 1 |
Altshuler, LL; Black, DO; Frye, MA; Grunze, H; Helleman, G; Keck, PE; Kupka, R; Leverich, GS; McElroy, SL; Mintz, J; Nolen, WA; Post, RM; Suppes, T | 1 |
Vitiello, B | 1 |
Altshuler, LL; Frye, MA; Grunze, H; Hellemann, G; Keck, PE; Kupka, RW; Leverich, GS; McElroy, SL; Nolen, WA; Post, RM; Sugar, CA; Suppes, T | 1 |
Hassan, M; Marcus, SC; Olfson, M | 1 |
Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
Martinez, DN; Martinez, TT | 1 |
Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A | 1 |
Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ | 1 |
Baumer, C; Koren, G; O'Brien, L; Sachs, H; Thieme, D | 1 |
Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
Agius, M; Gardner, J; Liu, K; Zaman, R | 3 |
Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
Cooper, NJ; Gordon, E; Koslow, SH; Nemeroff, CB; Rush, AJ; Schatzberg, AF; Williams, LM; Wisniewski, SR | 1 |
Bartell, SE; Furlong, ET; Logue, A; Painter, MM; Schoenfuss, HL; Schultz, MM; Werner, SL | 1 |
Beste, J; Blackwell, JC; Patel, BN | 1 |
Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T | 2 |
Barber, JP; Barrett, MS; Gallop, R; Rickels, K; Rynn, MA | 1 |
Kocsis, JH | 1 |
Dahmen, N; Engel, A; Gerbaulet, M; Hiemke, C | 1 |
Abbass, AA; Shedler, J; Town, JM | 1 |
Leelahanaj, T | 1 |
Fava, M; Perlis, RH; Perroud, N; Uher, R | 1 |
Eriksson, AC; Hägg, S; Hallbäck, I; Whiss, PA | 1 |
Adams, J; Graves, N; Solomon, D | 1 |
Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR | 1 |
Carlsson, J; Ekstrøm, M; Elklit, A; Mortensen, EL; Sonne, C | 1 |
Filov, I; Gerazova, VP; Marinov, P; Novotni, A; Ristevska-Dimitrovska, G; Shishkov, R; Stefanovski, B; Vujovik, V | 1 |
Etkin, A; Gordon, E; Grieve, SM; Harris, A; Korgaonkar, MS; Koslow, SH; Nemeroff, CB; Schatzberg, AF; Williams, LM; Wisniewski, S | 1 |
Al-Amin, MM; Rahman, MM; Rana, MS; Reza, HM; Uddin, MM | 1 |
Gibiino, S; Marsano, A; Serretti, A | 1 |
Roy-Byrne, P | 1 |
Hoge, EA; Keshaviah, A; Pollack, MH; Simon, NM; Stein, MB; Van Ameringen, M; Worthington, JW | 1 |
Jain, S | 1 |
Cooper, N; Gross, JJ; McRae, K; Rekshan, W; Williams, LM | 1 |
Dalrymple, KL | 1 |
Silberman, EK | 1 |
Pollack, MH; Simon, N; Stein, M; Van Ameringen, M | 1 |
Austin, PC; Gomes, T; Ho, JM; Juurlink, DN; Mamdani, M; Straus, SE | 1 |
Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
Arnow, BA; Boyce, PM; Day, CV; DeBattista, C; Etkin, A; Harris, AW; John Rush, A; Rekshan, W; Schatzberg, AF; Williams, LM | 1 |
Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM | 1 |
DeBattista, C; Etkin, A; Lazzeroni, LC; Murphy, GM; Schatzberg, AF; Williams, LM | 1 |
Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D | 1 |
McMahon, FJ | 1 |
12 review(s) available for cyclohexanol and sertraline
Article | Year |
---|---|
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
The use of newer antidepressants for panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Pharmacoeconomic studies of antidepressants: focus on venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Psychopharmacologic treatment of adolescent depression.
Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2001 |
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2008 |
Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.
Topics: Adrenergic Uptake Inhibitors; Cyclohexanols; Demography; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Randomized Controlled Trials as Topic; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2014 |
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride | 2015 |
33 trial(s) available for cyclohexanol and sertraline
Article | Year |
---|---|
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
Topics: Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Humans; Isoenzymes; Paroxetine; Phenotype; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Topics: Adult; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride | 2000 |
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.
Topics: Aged; Aged, 80 and over; Cyclohexanols; Depressive Disorder; Female; Frail Elderly; Geriatric Assessment; Humans; Male; Middle Aged; Nursing Homes; Patient Dropouts; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride | 2004 |
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
Topics: Adult; Ambulatory Care; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.
Topics: Adult; Citalopram; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bupropion; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Failure; Venlafaxine Hydrochloride | 2006 |
Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2006 |
A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Cyclohexanols; Depressive Disorder, Major; Drug Evaluation; Drug Interactions; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Venlafaxine Hydrochloride | 2006 |
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Risk Factors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
Topics: Adult; Antidepressive Agents; Citalopram; Corpus Striatum; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2007 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cyclohexanols; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Topics: Acute Disease; Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cognition; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Electroencephalography; Emotions; Europe; Female; Humans; Male; Middle Aged; Neuropsychological Tests; New Zealand; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Behavior; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2011 |
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Ethnicity; Female; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Psychotherapy, Brief; Sertraline; Sex Characteristics; Venlafaxine Hydrochloride | 2012 |
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult | 2013 |
Treatment of traumatized refugees with sertraline versus venlafaxine in combination with psychotherapy - study protocol for a randomized clinical trial.
Topics: Clinical Protocols; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Denmark; Humans; Psychiatric Status Rating Scales; Refugees; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; California; Citalopram; Clinical Protocols; Cognition; Cyclohexanols; Depressive Disorder, Major; Diffusion Tensor Imaging; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; New South Wales; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phobic Disorders; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Effects of antidepressant medication on emotion regulation in depressed patients: an iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Repression, Psychology; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2014 |
Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Risk Factors; Sertraline; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Remission Induction; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
71 other study(ies) available for cyclohexanol and sertraline
Article | Year |
---|---|
Serotonin reuptake inhibitors in Raynaud's phenomenon.
Topics: 1-Naphthylamine; Adult; Aged; Cyclohexanols; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1995 |
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Utilization; Humans; Mianserin; Middle Aged; Mirtazapine; Netherlands; Sertraline; Venlafaxine Hydrochloride | 1997 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
Erythromelalgia: response to serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Cyclohexanols; Erythromelalgia; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride | 1999 |
Acute liver damage possibly related to sertraline and venlafaxine ingestion.
Topics: Acute Disease; Adult; Antidepressive Agents; Cephalexin; Cephalosporins; Chemical and Drug Induced Liver Injury; Cyclohexanols; Drug Overdose; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide, Attempted; Venlafaxine Hydrochloride | 1999 |
Evidence of the dual mechanisms of action of venlafaxine.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Biological Transport, Active; Blood Platelets; Blood Pressure; Cyclohexanols; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Humans; Injections, Intravenous; Male; Maprotiline; Middle Aged; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Systole; Tyramine; Venlafaxine Hydrochloride | 2000 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Nonhormonal agents show promise against hot flashes.
Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Contraindications; Controlled Clinical Trials as Topic; Cyclohexanols; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Male; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women.
Topics: Adult; Amniotic Fluid; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Female; Fetal Blood; Fluvoxamine; Humans; Pregnancy; Sertraline; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 2000 |
Do antidepressants affect motivation in conditioned place preference?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclobutanes; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Motivation; Norepinephrine; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Venlafaxine versus sertraline for major depressive disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Serotonergic antidepressants and urinary incontinence.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride | 2000 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain | 2001 |
Prefrontal changes and treatment response prediction in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride | 2001 |
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Maprotiline; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2001 |
Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
Topics: Adult; Antidepressive Agents; Bosnia and Herzegovina; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Venlafaxine Hydrochloride; Warfare | 2001 |
Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.
Topics: Accidental Falls; Adult; Aged; Basal Ganglia Diseases; Cyclohexanols; Depressive Disorder; Dopamine Antagonists; Drug Interactions; Female; Humans; Metoclopramide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Tibial Fractures; Venlafaxine Hydrochloride | 2002 |
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Topics: Adult; Benzylamines; Carbon Radioisotopes; Carrier Proteins; Citalopram; Corpus Striatum; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2004 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Sertraline and venlafaxine: new indication. Prevention of recurrent depression: no advance.
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Approval; France; Humans; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Adolescents' response to antidepressant treatment in a community mental health center.
Topics: Adolescent; Adolescent Psychiatry; Algorithms; Antidepressive Agents; Child; Child Psychiatry; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Microchemistry; Mirtazapine; Piperazines; Reproducibility of Results; Sertraline | 2005 |
Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment.
Topics: Animals; Antidepressive Agents; Cyclohexanols; Electroconvulsive Therapy; Expressed Sequence Tags; Fluoxetine; Frontal Lobe; Imipramine; Male; Neuropeptides; Neuroserpin; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serpins; Sertraline; Venlafaxine Hydrochloride | 2006 |
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Chemistry; Carrageenan; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Duloxetine Hydrochloride; Edema; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Norepinephrine; Paroxetine; Pressure; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Venlafaxine Hydrochloride | 2006 |
Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine.
Topics: Anticholesteremic Agents; Antidepressive Agents; Atorvastatin; Bezoars; Calcium Channel Blockers; Cyclohexanols; Delayed-Action Preparations; Drug Overdose; Endoscopy, Digestive System; Fatal Outcome; Female; Heptanoic Acids; Humans; Middle Aged; Nifedipine; Pyrroles; Radiography; Sertraline; Stomach; Venlafaxine Hydrochloride | 2006 |
Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Emotions; Female; Fluoxetine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Mental Recall; Middle Aged; Paired-Associate Learning; Personality Inventory; Positron-Emission Tomography; Semantics; Sertraline; Venlafaxine Hydrochloride; Wechsler Scales | 2007 |
Antidepressant response in the elderly.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Sertraline versus venlafaxine XR in major depressive disorder.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2007 |
Flat dose-response curves for efficacy: what do they mean to the clinician?
Topics: Attitude of Health Personnel; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Physicians; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; United States; United States Food and Drug Administration | 2008 |
[A place for SSRIs in the treatment of severely depressed children and adolescents].
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Venlafaxine Hydrochloride | 2008 |
Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Cyclohexanols; Cyclopropanes; Dopamine; Duloxetine Hydrochloride; Homovanillic Acid; Male; Milnacipran; Norepinephrine; Organ Specificity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2009 |
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depression; Down-Regulation; Fenclonine; Male; Monoamine Oxidase Inhibitors; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Protein Synthesis Inhibitors; Protriptyline; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2009 |
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Sertraline; Statistics as Topic; Venlafaxine Hydrochloride; Young Adult | 2009 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Antidepressant switching among adherent patients treated for depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult | 2009 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
A case of serotonin syndrome associated with methadone overdose.
Topics: Adult; Cyclohexanols; Drug Overdose; Humans; Male; Methadone; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Suicide, Attempted; Venlafaxine Hydrochloride | 2008 |
Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Climacteric; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Morpholines; Personality Inventory; Reboxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2009 |
Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Female; Fluoxetine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Postpartum Period; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Sertraline; Venlafaxine Hydrochloride | 2010 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2010 |
Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Cyclohexanols; Cyprinidae; Endocrine Disruptors; Female; Fluoxetine; Male; Reproduction; Sertraline; Testis; Venlafaxine Hydrochloride; Vitellogenins; Water Pollutants, Chemical | 2011 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Evidence-Based Medicine; Female; Fluoxetine; Humans; Odds Ratio; Paroxetine; Physicians, Family; Pregnancy; Pregnancy Complications; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2011 |
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
Topics: Adult; Bias; Bupropion; Buspirone; Cluster Analysis; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Approval; Female; Humans; Male; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Sertraline; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2012 |
High venlafaxine serum levels after prior fluoxetine medication.
Topics: Antidepressive Agents, Second-Generation; Cholinergic Antagonists; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2012 |
Evidence for short-term psychodynamic psychotherapy for depression.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy, Brief; Sertraline | 2012 |
Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Models, Economic; Quality of Life; Sertraline; Thailand; Venlafaxine Hydrochloride | 2012 |
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride | 2012 |
In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Blood Coagulation; Blood Platelets; Citalopram; Cyclohexanols; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Platelet Adhesiveness; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2012 |
Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Australia; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Hypericum; Markov Chains; Middle Aged; Models, Economic; Phytotherapy; Plant Preparations; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Bulgaria; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Republic of North Macedonia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Astrocytes; Cells, Cultured; Cyclohexanols; Diclofenac; Enzyme-Linked Immunosorbent Assay; Fluvoxamine; Interleukin-10; Lipopolysaccharides; Mice; Pyridoxine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2013 |
Treatment in nonresponsive patients with social anxiety: back to the future with benzodiazepines.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline; Venlafaxine Hydrochloride | 2014 |
Journal Watch review of Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy, Brief; Sertraline | 2014 |
Longer term outcomes need to be examined for enhancing the treatment of social anxiety disorder after insufficient improvement with sertraline.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline | 2014 |
The role of benzodiazepines in treating social anxiety disorder.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline | 2014 |
Response to Silberman.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline | 2014 |
Adverse cardiac events in older patients receiving venlafaxine: a population-based study.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cohort Studies; Comorbidity; Cyclohexanols; Drug Interactions; Female; Heart Failure; Humans; Hypertension; Male; Myocardial Infarction; Ontario; Retrospective Studies; Risk Factors; Sertraline; Tachycardia; Venlafaxine Hydrochloride | 2014 |
Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here?
Topics: Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Sertraline | 2015 |